What's New at CBER 3/1/2024 U.S. Food and Drug Administration sent this bulletin at 03/01/2024 04:30 PM EST What's New at CBER You are subscribed to What's New at CBER for the U.S. Food & Drug Administration (FDA) What's New Today The following links have been updated recently: Posted: 3/1/2024 Clinical Pharmacology Considerations for Antibody-Drug Conjugates; Guidance for Industry Key Information and Facilitating Understanding in Informed Consent; Draft Guidance for Sponsors, Investigators, and Institutional Review Boards Information for Health Professionals on “Partial Heart Transplantation" Workshops, Meetings & Conferences March Vaccines and Related Biological Products Advisory Committee MeetingMarch 5, 2024 Considerations for the Development of CAR T Cell ProductsMarch 7, 2024 May Vaccines and Related Biological Products Advisory Committee MeetingMay 16, 2024